It has also been shown that overexpression of an oncogenic form of erbB2 leads to strong expression of LIPG (Cadenas et al., 2012[4]) and LIPG has been reported to be associated with tumor growth (Slebe et al., 2016[17]) and with metastasis in triple-negative breast cancer (Lo et al., 2018[11]). This evidence concerns the gene LIPG and triple-negative breast carcinoma.